Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folvitra is a nutritional supplement, often categorized as a medical food, developed by Blue Heron Pharmaceuticals for the dietary management of patients with folate deficiency and for prenatal nutritional support. It is formulated with a combination of bioactive B-vitamins in their active forms: L-methylfolate (as L-methylfolate calcium), Vitamin B12 (as methylcobalamin), and Vitamin B6 (as pyridoxal 5-phosphate). These specific forms are utilized to ensure high bioavailability and to bypass the enzymatic conversion steps required by synthetic vitamins, which is particularly beneficial for individuals with genetic polymorphisms such as those affecting the methylenetetrahydrofolate reductase (MTHFR) enzyme. Folvitra supports the methylation cycle, aids in the reduction of homocysteine levels, and provides essential nutrients for DNA synthesis and neural development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Folvitra.